Golden
Pfizer Ventures

Pfizer Ventures

U.S-based venture capital firm investing on bio-pharmaceutical and neuroscience companies.

Pfizer Ventures, also known as Pfizer Venture Investments, is a venture capital firm founded in 2004. The firm is a subsidiary of Pfizer. It is based in New York City, New York. As of March 2019, the firm has 45 active companies in its portfolio and has sold off its ownership in 58 companies. Its most recent investment is in Imara on March 2019, a company developing therapeutics for individuals with sickle cell diseases.

Funding

Pfizer Ventures focuses on funding companies in the field of bio-pharmaceuticals and neuroscience. The firm primarily seeks to fund companies that are based in the United States, although it also allocates 20% of its investments for non-U.S. companies. It finances companies at various stages, from early to growth. Since its conception, it has managed to collect $600 million from one funding round held in June 2018.

Timeline

People

Name
Role
Related Golden topics

Barbara Dalton

Vice President/Senior Managing Partner



Bill Burkoth

Senior Director



Denis Patrick

Vice President/Managing Partner



Elaine Jones

Vice President/Senior Partner



Laszlo Kiss

Principal/Executive Director



William Burkoth

Executive Director



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

4D Molecular Therapeutics







Artios Pharma







Biodesy







Imara







Kymera Therapeutics







Nimbus Therapeutics







System1 Biosciences







References